1-7 of 7
Michael E. Trigg
Close
Sort by
Journal Articles

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

Clinical Trials & Observations
Corey S. Cutler, Stephanie J. Lee, Peter Greenberg, H. Joachim Deeg, Waleska S. Pérez, Claudio Anasetti, Brian J. Bolwell, Mitchell S. Cairo, Robert Peter Gale, John P. Klein, Hillard M. Lazarus, Jane L. Liesveld, Philip L. McCarthy, Gustavo A. Milone, J. Douglas Rizzo, Kirk R. Schultz, Michael E. Trigg, Armand Keating, Daniel J. Weisdorf, Joseph H. Antin, Mary M. Horowitz
Journal: Blood
Blood (2004) 104 (2): 579–585.
https://doi.org/10.1182/blood-2004-01-0338
Published: 2004
Journal Articles

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Clinical Trials & Observations
Bruce C. Bostrom, Martha R. Sensel, Harland N. Sather, Paul S. Gaynon, Mei K. La, Katherine Johnston, Gary R. Erdmann, Stuart Gold, Nyla A. Heerema, Raymond J. Hutchinson, Arthur J. Provisor, Michael E. Trigg
Journal: Blood
Blood (2003) 101 (10): 3809–3817.
https://doi.org/10.1182/blood-2002-08-2454
Published: 2003
Journal Articles

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

Clinical Trials & Observations
Smita Bhatia, Harland N. Sather, Nyla A. Heerema, Michael E. Trigg, Paul S. Gaynon, Leslie L. Robison
Journal: Blood
Blood (2002) 100 (6): 1957–1964.
https://doi.org/10.1182/blood-2002-02-0395
Published: 2002
Journal Articles

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983

Clinical Trials & Observations
Smita Bhatia, Harland N. Sather, Olga B. Pabustan, Michael E. Trigg, Paul S. Gaynon, Leslie L. Robison
Journal: Blood
Blood (2002) 99 (12): 4257–4264.
https://doi.org/10.1182/blood.V99.12.4257
Published: 2002
Journal Articles

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Clinical Trials & Observations
Beverly J. Lange, Bruce C. Bostrom, Joel M. Cherlow, Martha G. Sensel, Mei K. L. La, Wayne Rackoff, Nyla A. Heerema, Robert S. Wimmer, Michael E. Trigg, Harland N. Sather
Journal: Blood
Blood (2002) 99 (3): 825–833.
https://doi.org/10.1182/blood.V99.3.825
Published: 2002
Journal Articles

Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia

Fatih M. Uckun, Martha G. Sensel, Lei Sun, Peter G. Steinherz, Michael E. Trigg, Nyla A. Heerema, Harland N. Sather, Gregory H. Reaman, Paul S. Gaynon
Journal: Blood
Blood (1998) 91 (3): 735–746.
https://doi.org/10.1182/blood.V91.3.735
Published: 1998
Journal Articles

Clinical Features and Treatment Outcome of Children With Myeloid Antigen Positive Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Fatih M. Uckun, Harland N. Sather, Paul S. Gaynon, Diane C. Arthur, Michael E. Trigg, David G. Tubergen, James Nachman, Peter G. Steinherz, Martha G. Sensel, Gregory H. Reaman
Journal: Blood
Blood (1997) 90 (1): 28–35.
https://doi.org/10.1182/blood.V90.1.28
Published: 1997